VVOS
Vivos Therapeutics, Inc.
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Without additional financing, these factors raise substantial doubt regarding the Company’s ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Company with tickers: VVOS
CIK
1716166
CUSIP
92859E207
Shares Outstanding
13,894,600
Website
https://www.vivos.com
Investor Relations
https://vivos.com/investors/
13F Activity (30d)
2 filings
1 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.